Maybe the report will come out late this week. Perhaps more likely next week. I hope it gives a good run down on how our retail sales are going/improving.
The clinical trial sales are useful - but not long term and so cloud the issue of whether or not we are actually improving our retail market penetration. There have been some indications from management recently that our market presentatiuon is going well. I hope that is shown to be continuing.
RHT Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
